论文部分内容阅读
我院内科在1986～1988年间,应用乙胺碘呋酮(AI)转复17例房颤(Af),现报告如下。 1 临床资料本组17例中,男10例,女7例,年龄33～84岁。其中冠心病11例,风心病6例。Af时间最短者2周,最长者10年,均经心电图证实。无Af复律禁忌证。 2 给药方法均采用口服法给药:AI的起始剂量为0,6～0.8g/d,分3～4次服用,有效后逐渐减至最小有效维持量0.2g/d,长期连续或间歇服用(每周服5d停2d)并定期随访。凡心衰明显者均将其纠正后再开始用药。服AI前3d开始静点含镁极化
The Department of Internal Medicine in 1986 to 1988, the application of amiodarone (AI) in 17 cases of atrial fibrillation (Af), are as follows. 1 Clinical data The group of 17 cases, 10 males and 7 females, aged 33 to 84 years. Including coronary heart disease in 11 cases, 6 cases of rheumatic heart disease. Af the shortest 2 weeks, the longest 10 years, confirmed by ECG. No Af cardioversion contraindications. 2 administration methods are used oral administration: AI starting dose of 0,6 ~ 0.8g / d, 3 to 4 times taken, effectively reduced to the minimum effective maintenance of 0.2g / d, long-term continuous or Intermittent (weekly 5d stop 2d) and regular follow-up. Where obvious heart failure who will be corrected before starting medication. Served before AI static point containing magnesium polarization